Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Jun;13(3):188-95.
doi: 10.1016/j.clbc.2012.12.002. Epub 2013 Jan 29.

Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese

Cheryl L Rock  1 , Chetna Pande, Shirley W Flatt, Carl Ying, Bilge Pakiz, Barbara A Parker, Kathryn Williams, Wayne A Bardwell, Dennis D Heath, Jeanne F Nichols
Affiliations

Favorable changes in serum estrogens and other biologic factors after weight loss in breast cancer survivors who are overweight or obese

Cheryl L Rock et al. Clin Breast Cancer. 2013 Jun.

Abstract

Background: Obesity is associated with an increased risk for recurrence and all-cause mortality in breast cancer survivors. Excess adiposity is associated with increased estrogen, insulin, and leptin, and with decreased sex hormone binding globulin (SHBG) concentrations, which may promote breast cancer progression and recurrence. This study aimed to assess the effects of weight loss on these factors.

Patients and methods: Breast cancer survivors who were overweight or obese (n = 220) and who were enrolled in a weight loss intervention study provided baseline and follow-up blood samples and weight data. Serum estrogens, SHBG, insulin, and leptin were measured at baseline, 6 months, and 18 months.

Results: Weight loss of ≥5% of initial weight decreased leptin and insulin compared with those who did not achieve that amount of weight loss (P < .0001). Weight loss also increased SHBG at 6 and 18 months (P < .01). Postmenopausal women who lost ≥5% of body weight at 6 months had lower estrone (P = .02), estradiol (P = .002), and bioavailable estradiol (P = .001) concentrations than women who did not lose at least 5% of body weight, and weight loss at 18 months was significantly related to a change in serum bioavailable estradiol concentration (P = .02).

Conclusions: Favorable changes in estrogens, SHBG, insulin, and leptin were observed in association with weight loss in these women who were overweight or obese and who had been diagnosed and treated for breast cancer. Weight loss appears to have favorable effects on hormonal and biologic factors associated with increased risk for recurrence and poorer prognosis.

Trial registration: ClinicalTrials.gov NCT00774371.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest

The authors have stated that they have no conflicts of interest.

References

    1. American Cancer Society. [Accessed June 11, 2012];What are the key statistics about breast cancer? http://www.cancer.org.
    1. Chlebowski RT, Aiello E, McTiernan A. Weight loss in breast cancer patient management. J Clin Oncol. 2002;20(4):1128–1143. - PubMed
    1. Kroenke CH, Chen WY, Rosner B, Holmes MD. Weight, weight gain, and survival after breast cancer diagnosis. J Clin Oncol. 2005;23(7):1370–1378. - PubMed
    1. Majed B, Moreau T, Senouci K, Salmon RJ, Fourquet A, Asselain B. Is obesity an independent prognosis factor in woman breast cancer? Breast Cancer Res Treat. 2008;111(2):329–342. - PubMed
    1. Protani M, Coory M, Martin JH. Effect of obesity on survival of women with breast cancer: systematic review and meta-analysis. Breast Cancer Res Treat. 2010;123(3):627–635. - PubMed

Publication types

Associated data